Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the Ovary

OBJECTIVE: The objective of this study was to evaluate the antitumor effects of lurbinectedin as a single agent or in combination with existing anticancer agents for clear cell carcinoma (CCC) of the ovary, which is regarded as an aggressive, chemoresistant, histological subtype. METHODS: Using huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Ryoko, Mabuchi, Seiji, Kawano, Mahiru, Sasano, Tomoyuki, Matsumoto, Yuri, Kuroda, Hiromasa, Kozasa, Katsumi, Hashimoto, Kae, Sawada, Kenjiro, Kimura, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795692/
https://www.ncbi.nlm.nih.gov/pubmed/26986199
http://dx.doi.org/10.1371/journal.pone.0151050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795692/
https://www.ncbi.nlm.nih.gov/pubmed/26986199
http://dx.doi.org/10.1371/journal.pone.0151050

Ejemplares similares